We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,739 results
  1. Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis

    Introduction

    Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions with high morbidity and...

    Jiali Cao, Xuan Zhang, ... Jie Fan in Dermatology and Therapy
    Article Open access 13 May 2023
  2. Comment on: Proposal for a new diagnostic classification of photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis

    Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap (SJS/TEN), collectively referred to SJS/TEN, form a spectrum of...

    Bukiwe N. Thwala, Nadine Teixeira, ... Rannakoe J. Lehloenya in European Journal of Medical Research
    Article Open access 29 January 2024
  3. Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review

    The aim of our review article was to summarize the current literature on Stevens–Johnson syndrome (SJS) and its severe form, toxic epidermal...

    Gábor Tóth, Andrea Lukács, ... Nóra Szentmáry in Ophthalmology and Therapy
    Article Open access 04 May 2023
  4. Photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification

    Background

    Ultraviolet radiation (UVR) exposure is commonly reported as a risk factor for Stevens–Johnson syndrome (SJS) and toxic epidermal...

    Blake Jeffrey McKinley, Mitchell Edger Allen, Nicole Michels in European Journal of Medical Research
    Article Open access 12 June 2023
  5. The outcomes of corneal sight rehabilitating surgery in Stevens-Johnson syndrome: case series

    Purpose

    To summarize the outcomes of corneal sight rehabilitating surgery in Stevens-Johnson syndrome (SJS).

    Methods

    This is a retrospective analysis...

    Rongmei Peng, Miaomiao Chi, ... **g Hong in BMC Ophthalmology
    Article Open access 06 May 2024
  6. Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab

    Background

    Osimertinib has emerged as an important tool in the treatment of non-small cell lung cancers (NSCLC) with certain activating mutations of...

    Michael Lopez, Garo Hagopian, ... Misako Nagasaka in Allergy, Asthma & Clinical Immunology
    Article Open access 28 October 2023
  7. Clinical Characteristics and Treatment of Ophthalmic Sequelae of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Eyecare Centre in Hungary

    Introduction

    This study analysed the causative factors and clinical characteristics of acute and chronic ocular sequelae of Stevens–Johnson syndrome...

    Gábor Tóth, Andrea Lukács, ... Nóra Szentmáry in Ophthalmology and Therapy
    Article Open access 20 March 2024
  8. Pediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a national analysis of 2016 Kids’ Inpatient Database

    Pediatric-specific studies on Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are lacking. The objective of this study was to...

    Julianne M. Falotico, Amar D. Desai, Shari R. Lipner in Archives of Dermatological Research
    Article 20 October 2022
  9. Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study

    Background

    Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and extremely serious drug-induced dermatological disorders....

    Yingyi Liu, Jianing Feng, ... Yan He in BMC Ophthalmology
    Article Open access 03 July 2023
  10. Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients

    Introduction

    Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening acute mucocutaneous disorders usually triggered...

    Funda Erduran, Esra Adışen, ... Akın Aktaş in Dermatology and Therapy
    Article Open access 17 May 2024
  11. Corneal Histopathology in Stevens-Johnson Syndrome: A Case Report and Review of Literature

    Stevens-Johnson syndrome is a life-threatening, immune-mediated, acute inflammatory disorder of the mucocutaneous membranes. It affects people of...

    Eylul Gun, Erdener Ozer in SN Comprehensive Clinical Medicine
    Article 18 June 2022
  12. Cytokeratin profile and keratinocyte gene expression in keratinized lid margins of patients with chronic Stevens-Johnson syndrome

    Purpose

    To study the cytokeratin profile and keratinization-related gene expression in keratinized lid margins of chronic Stevens-Johnson syndrome...

    Madhuri Amulya Koduri, Jilu Jaffet, ... Swati Singh in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 23 April 2022
  13. Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome

    Background

    Stevens-Johnson syndrome (SJS) is an abnormal immune-response causing extensive exfoliation of the mucocutaneous tissue including...

    Jayoon Moon, Yun** Lee, ... Mee Kum Kim in BMC Ophthalmology
    Article Open access 19 April 2022
  14. Corona virus disease 2019-associated Stevens-Johnson syndrome: a case report

    Background

    To report Stevens-Johnson syndrome (SJS) in a patient with acute pneumonia secondary to SARS-CoV-2 infection.

    Case presentation ...
    Toktam Shahraki, Kiana Hassanpour, ... Mohammad-Mehdi Sadoughi in BMC Ophthalmology
    Article Open access 12 July 2021
  15. Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study

    Objective

    Our objective was to describe the incidence of Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) in a large unselected cohort,...

    Naomi Gronich, David Maman, ... Walid Saliba in American Journal of Clinical Dermatology
    Article 04 February 2022
  16. Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens–Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN

    Pediatric Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threating blistering diseases triggered by...

    Michele L. Ramien, Danny Mansour, Neil H. Shear in Pediatric Drugs
    Article 09 June 2022
  17. Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases

    Immune checkpoint inhibitor (ICI) therapies carry the risk of major immune-related adverse events (irAEs). Among the most severe irAEs is epidermal...

    Eric R. Bray, Rachel R. Lin, ... Andrea D. Maderal in Archives of Dermatological Research
    Article 25 May 2024
  18. Armodafinil-Associated Stevens-Johnson Syndrome: a Case Report

    Stevens-Johnson syndrome and toxic epidermal necrolysis are two overlap** presentations of the same clinical condition. The diseases typically...

    Isabelle Zare, Olasunkanmi W. Adeyinka, Jude K. A. des Bordes in SN Comprehensive Clinical Medicine
    Article 16 April 2021
Did you find what you were looking for? Share feedback.